CD4 and COVID-19: Interestingly, we found that COVID-19 patients with neutrophilia, lymphopenia and a more pronounced alteration in the biochemical parameters associated to inflammation had a higher percentage of CD4+ T cells with expression of activation markers HLA-DR and CD38.